Periventricular Leukomalacia
22
1
2
12
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
18.2%
4 terminated out of 22 trials
75.0%
-11.5% vs benchmark
18%
4 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (22)
Randomized Controlled Trial of Early Intensive Leg Exercise to Improve Walking in Children With Diplegia
Spinal Stimulation and Mobility Devices
Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia
Prediction of Brain Injury in Premature Infants
A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
Antibiotic "Dysbiosis" in Preterm Infants
Sonographic QUantification of Venous Circulation In the Preterm Brain
Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill
Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill
PUFAs in Preterm Infants
Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury
Single-session tDCS in Cerebral Palsy
MISA to NRDS：a Multicenter Study in China
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Does Erythropoietin Improve Outcome in Very Preterm Infants?
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
Telerehabilitation of Working Memory in Children With Periventricular Leukomalacia and Bilateral Cerebral Palsy
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study